Revolutionary new treatment regimens for multidrug-resistant tuberculosis.
Lancet Infect Dis. 2019 Mar;19(3):233-234. doi: 10.1016/S1473-3099(19)30060-X.
Lancet Infect Dis. 2019.
PMID: 30833051
No abstract available.